Microsoft Corporation Co-Founder Paul Allen To Donate Majority Of His Estate To Cancer Research & Other Non Profit Projects

Hey–check-out this article about Microsoft co-founder and cancer survivor Paul Allen:
Microsoft co-founder pledges fortune to philanthropy
Thu Jul 15, 2010
Microsoft Corp (MSFT.O) co-founder Paul Allen, who has been treated for non-Hodgkin’s lymphoma, said on Thursday he is committing most of his estimated $13.5 billion fortune to philanthropy after his death.

Good Morning From ASH! How Exciting! Let’s Look At Some… Posters?

The real excitement here starts at 2:30. That is when the major newsworthy studies, as determined by the ASH board, begin to be presented. Until then, all is speculation and rumor. They call in an information embargo. Drug company reps and researchers aren’t allowed to discuss details of their clinical studies until they are presented this afternoon, evening, all day Monday and ending Tuesday. Studies deemed less significant are relegated to a large room of “poster presentations.” I spent a lot of time there this morning and found it fascinating. You walk into a large exhibit hall (about the size of four football fields) and before you stand row upon row of display boards. Pinned to these boards are 4′ x 6′ posters. Each poster is a color reproduction of a scientific journal study, just like you would find on line. Studies are grouped by topic. For example, clinical data on non-Hodgkins lymphoma would be grouped in one section in one row. It’s sort of cool yet silly all at the same time… Instead of reading grouped studies on computer, you are walking up and down between these rows of posters. Most don’t even have handouts available. Some people take notes, some take pictures. All seem to be in English. The lead researchers of the studies are scheduled to be present in two hour blocks once or twice during the conference to answer questions. The draw seems to be the immediacy of it all–these studies won’t be published and available on-line until after the conference concludes next week.

Lymphoma Diagnosis Featured On ABC Drama "Brothers & Sisters

One of the characters on the ABC Sunday night drama, “Brothers and Sisters,” was told tonight she has “Stage III lymphoma,” and the recommended treatment on the program was is R-CHOP. I know it is only a TV show, but Pattie and I are always intrigued by how Hollywood portrays how cancer effects friends and families. And call us unrealistic or difficult, but we also like accuracy in my cancer dramas. As movies and programs go, this storyline isn’t so bad. Working our way backward, we can assume the character, Kitty, has Stage III non-Hodgkins lymphoma. Here is what About.Com says about R-CHOP:

Exciting But Confusing News For Lymphoma Patients

Found this article this morning on a site called RobertsReview.Com. There must be a catch. I can’t believe such treatments exist and aren’t being used or embraced by oncologists for selfish reasons like article claims in the last paragraph. No study sited or author listed so read it carefully and with a skeptical eye:

Non Hodgkin’s-Lymphoma

Hon-Hodgkin’s Lymphomas are the second leading cause of cancer deaths in patients ages fifteen to thirty-four and the third leading cause of cancer deaths in patients ages thirty-one to fifty-four. An estimated 63,190 new cases of Non-Hodgkin’s Lymphoma were diagnosed in the United States during 2007, according to the book Everyone’s Guide to Cancer Therapy. This is a difficult type of cancer to cure. But depending on the specific type of Non-Hodgkin’s Lymphoma and how early the cancer is identified, patients often can live many years with good treatment and follow-up care. For more information about Non-Hodgkin’s Lymphoma, click on the Leukemia and Lymphoma Society link on the right side of the page.

Five Most Common Cancers In Women

Since it’s mother’s day, I felt it was appropriate to post about a topic important to women. EverydayHealth.Com featured an article yesterday listing the five most common types of cancer among women. I found it interesting/helpful because it also gave survival data and percentages of women affected. The five most common cancers in women are: